Monthly Costs Breakdown: Plan Your Budget Ahead
What the Difference Between Mounjaro and Wegovy Monthly Costs Really Means
The key distinction when comparing what the difference between Mounjaro and Wegovy monthly costs involves understanding their different dose escalation schedules. Wegovy follows a structured 16-week escalation starting at 0.25mg (£79.99 monthly with code FIRST40), progressing through 0.5mg (£94.99), 1mg (£99.99), and 1.7mg (£139.99) before reaching the 2.4mg maintenance dose at £209.99 per month. This prescription-only medicine requires clinical assessment and prescriber approval at each stage.
Mounjaro's escalation schedule differs, with tirzepatide doses increasing every four weeks from 2.5mg to a maximum of 15mg, creating a different monthly cost structure. Understanding what the difference between Mounjaro and Wegovy pricing structures means helps you budget effectively for long-term weight management alongside a reduced-calorie diet and increased physical activity. Your choice between these treatments should consider both clinical suitability and ongoing financial commitment.
Wegovy Pricing Structure and Bundle Savings Through EverydayMeds
At EverydayMeds GPhC #9012878, we offer transparent pricing for every Wegovy dose with new customer code FIRST40 and returning customer code DOSE25 applied at checkout. Single pen prices progress from £79.99 (0.25mg starter) through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg pens) cost £169.99, providing your first two months' supply in one convenient order.
When comparing what the difference between Mounjaro and Wegovy bundle options reveals, Wegovy's structured progression allows for targeted purchasing. Our Step-Up bundles such as the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 cover months 2-4 of treatment, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. These bundles ensure treatment continuity without multiple orders, particularly important for this prescription-only medicine requiring consistent supply.
Clinical Evidence Distinguishing Mounjaro and Wegovy Effectiveness
The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events. These results reflect Wegovy's single GLP-1 receptor agonist mechanism.
Mounjaro's dual GIP and GLP-1 receptor agonist mechanism showed different trial results in the SURMOUNT studies, though direct comparisons cannot be made due to different trial designs and patient populations. Understanding what the difference between Mounjaro and Wegovy clinical profiles means requires discussion with your prescriber, who can assess which treatment aligns with your medical history and weight management goals.
How Wegovy's Mechanism Affects Monthly Treatment Value
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This mechanism works by reducing appetite and promoting feelings of fullness after smaller meals, potentially reducing food cravings by acting on brain appetite centres. The once-weekly injection allows consistent hormone level maintenance, which may contribute to sustainable appetite control throughout each month of treatment. Understanding this mechanism helps explain why consistent monthly dosing is crucial for optimal results. The medication works alongside lifestyle modifications rather than replacing them, meaning your monthly investment supports a comprehensive weight management approach.
Streamlined Ordering Process for Both Treatments
EverydayMeds simplifies access to both Wegovy and Mounjaro through our 3-minute online clinical assessment, designed to gather essential medical information efficiently. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your suitability for either treatment. Once approved, we dispatch your prescription-only medicine via next-day delivery using temperature-controlled, cold-chain logistics to maintain medication integrity. Our process includes clear dosing instructions and ongoing support throughout your treatment journey. This streamlined approach means you can focus on your weight management goals rather than complex ordering procedures.
Storage Requirements and Practical Considerations
Both Wegovy and Mounjaro require refrigeration at 2-8°C before first use, but their room temperature stability differs significantly. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro allows only 21 days room temperature storage. This storage advantage makes Wegovy more suitable for travel or situations where refrigeration access is limited. The FlexTouch pen design provides consistent dose delivery throughout the 16-week escalation period. Understanding these practical differences helps inform your choice between treatments, particularly if lifestyle factors like frequent travel affect your routine.
Long-term Budget Planning: What the Difference Between Mounjaro and Wegovy Annual Costs Reveals
Planning your annual budget requires understanding what the difference between Mounjaro and Wegovy long-term costs involves beyond initial monthly payments. Wegovy's maintenance dose at £209.99 monthly equals £2,519.88 annually for established patients using code DOSE25. The first year includes escalation costs totalling approximately £724.96 for the initial 16 weeks, followed by maintenance pricing. This transparent pricing structure allows accurate financial planning for sustained weight management.
When evaluating what the difference between Mounjaro and Wegovy represents financially, consider that both treatments showed weight regain when discontinued in clinical trials, with patients regaining approximately two-thirds of lost weight within one year of stopping. This evidence suggests weight management requires long-term commitment, making annual cost planning essential rather than viewing these treatments as short-term interventions.
Expert Clinical Assessment and Ongoing Support Value
Every EverydayMeds patient receives thorough clinical evaluation to determine whether Wegovy, Mounjaro, or alternative treatments best suit their individual circumstances. Our prescribers assess your BMI, medical history, current medications, and weight management goals before recommending treatment. This personalised approach ensures your monthly investment aligns with clinical appropriateness rather than personal preference alone. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment offers optimal value for your specific situation. We provide ongoing monitoring support throughout your journey, ensuring your monthly costs translate into meaningful health outcomes. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which treatment represents the best investment in your health goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
